389 related articles for article (PubMed ID: 34192364)
1. Repurposing existing therapeutics, its importance in oncology drug development: Kinases as a potential target.
Islam S; Wang S; Bowden N; Martin J; Head R
Br J Clin Pharmacol; 2022 Jan; 88(1):64-74. PubMed ID: 34192364
[TBL] [Abstract][Full Text] [Related]
2. Computer-aided drug repurposing for cancer therapy: Approaches and opportunities to challenge anticancer targets.
Mottini C; Napolitano F; Li Z; Gao X; Cardone L
Semin Cancer Biol; 2021 Jan; 68():59-74. PubMed ID: 31562957
[TBL] [Abstract][Full Text] [Related]
3. Repurposing of drugs: An attractive pharmacological strategy for cancer therapeutics.
Kirtonia A; Gala K; Fernandes SG; Pandya G; Pandey AK; Sethi G; Khattar E; Garg M
Semin Cancer Biol; 2021 Jan; 68():258-278. PubMed ID: 32380233
[TBL] [Abstract][Full Text] [Related]
4. Protective role of anticancer drugs in neurodegenerative disorders: A drug repurposing approach.
Advani D; Gupta R; Tripathi R; Sharma S; Ambasta RK; Kumar P
Neurochem Int; 2020 Nov; 140():104841. PubMed ID: 32853752
[TBL] [Abstract][Full Text] [Related]
5. Drug rechanneling: A novel paradigm for cancer treatment.
Kaushik I; Ramachandran S; Prasad S; Srivastava SK
Semin Cancer Biol; 2021 Jan; 68():279-290. PubMed ID: 32437876
[TBL] [Abstract][Full Text] [Related]
6. Repurposing of drugs as STAT3 inhibitors for cancer therapy.
Thilakasiri PS; Dmello RS; Nero TL; Parker MW; Ernst M; Chand AL
Semin Cancer Biol; 2021 Jan; 68():31-46. PubMed ID: 31711994
[TBL] [Abstract][Full Text] [Related]
7. Repurposing Drugs in Oncology: Next Steps.
Verbaanderd C; Meheus L; Huys I; Pantziarka P
Trends Cancer; 2017 Aug; 3(8):543-546. PubMed ID: 28780930
[TBL] [Abstract][Full Text] [Related]
8. Applications of promiscuity of FDA-approved kinase inhibitors in drug repositioning and toxicity.
Korikani M; Fathima N; Nadiminti G; Akula S; Kancha RK
Toxicol Appl Pharmacol; 2023 Apr; 465():116469. PubMed ID: 36918129
[TBL] [Abstract][Full Text] [Related]
9. Machine and deep learning approaches for cancer drug repurposing.
Issa NT; Stathias V; Schürer S; Dakshanamurthy S
Semin Cancer Biol; 2021 Jan; 68():132-142. PubMed ID: 31904426
[TBL] [Abstract][Full Text] [Related]
10. Repurposing drugs in oncology: From candidate selection to clinical adoption.
Pantziarka P; Verbaanderd C; Huys I; Bouche G; Meheus L
Semin Cancer Biol; 2021 Jan; 68():186-191. PubMed ID: 31982510
[TBL] [Abstract][Full Text] [Related]
11. Drug repurposing-an emerging strategy in cancer therapeutics.
Turabi KS; Deshmukh A; Paul S; Swami D; Siddiqui S; Kumar U; Naikar S; Devarajan S; Basu S; Paul MK; Aich J
Naunyn Schmiedebergs Arch Pharmacol; 2022 Oct; 395(10):1139-1158. PubMed ID: 35695911
[TBL] [Abstract][Full Text] [Related]
12. Repurposing approved non-oncology drugs for cancer therapy: a comprehensive review of mechanisms, efficacy, and clinical prospects.
Mohi-Ud-Din R; Chawla A; Sharma P; Mir PA; Potoo FH; Reiner Ž; Reiner I; Ateşşahin DA; Sharifi-Rad J; Mir RH; Calina D
Eur J Med Res; 2023 Sep; 28(1):345. PubMed ID: 37710280
[TBL] [Abstract][Full Text] [Related]
13. Drug repurposing a compelling cancer strategy with bottomless opportunities: Recent advancements in computational methods and molecular mechanisms.
Dash R; Yadav M; Biswal J; Samanta S; Sharma T; Mohapatra S
Indian J Pharmacol; 2023; 55(5):322-331. PubMed ID: 37929411
[TBL] [Abstract][Full Text] [Related]
14. Drug repurposing in oncology: Compounds, pathways, phenotypes and computational approaches for colorectal cancer.
Nowak-Sliwinska P; Scapozza L; Ruiz i Altaba A
Biochim Biophys Acta Rev Cancer; 2019 Apr; 1871(2):434-454. PubMed ID: 31034926
[TBL] [Abstract][Full Text] [Related]
15. Turning liabilities into opportunities: Off-target based drug repurposing in cancer.
Palve V; Liao Y; Remsing Rix LL; Rix U
Semin Cancer Biol; 2021 Jan; 68():209-229. PubMed ID: 32044472
[TBL] [Abstract][Full Text] [Related]
16. Computational Drug Repurposing: Classification of the Research Opportunities and Challenges.
Sadeghi SS; Keyvanpour MR
Curr Comput Aided Drug Des; 2020; 16(4):354-364. PubMed ID: 31198115
[TBL] [Abstract][Full Text] [Related]
17. Drug repurposing for cancer therapy, easier said than done.
Gonzalez-Fierro A; Dueñas-González A
Semin Cancer Biol; 2021 Jan; 68():123-131. PubMed ID: 31877340
[TBL] [Abstract][Full Text] [Related]
18. Artificial intelligence, machine learning, and drug repurposing in cancer.
Tanoli Z; Vähä-Koskela M; Aittokallio T
Expert Opin Drug Discov; 2021 Sep; 16(9):977-989. PubMed ID: 33543671
[No Abstract] [Full Text] [Related]
19. Can Drug Repurposing Accelerate Precision Oncology?
Schipper LJ; Zeverijn LJ; Garnett MJ; Voest EE
Cancer Discov; 2022 Jul; 12(7):1634-1641. PubMed ID: 35642948
[TBL] [Abstract][Full Text] [Related]
20. Computationally-guided drug repurposing enables the discovery of kinase targets and inhibitors as new schistosomicidal agents.
Giuliani S; Silva AC; Borba JVVB; Ramos PIP; Paveley RA; Muratov EN; Andrade CH; Furnham N
PLoS Comput Biol; 2018 Oct; 14(10):e1006515. PubMed ID: 30346968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
